— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read More
— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read MorePicture the scene. It’s 2003 in Tallinn, Estonia. Taavet Hinrikus, a 20-year-old computer whiz, has just accepted an offer to…
Read More